Senior Partner, Evidence, Value, Access & Pricing (EVAP), Trinity Life Sciences

Board Member: Elected 2022

AB, Dartmouth
BE, Thayer School of Engineering at Dartmouth

Monica A. Martin de Bustamante's career has focused on global pricing and market access issues for biopharmaceutical and pharmaceutical products, and has extensive experience working across major therapeutic areas (oncology, cardiovascular, neurology, metabolic, autoimmune, gastrointestinal, respiratory, etc.) to collaborate on products from early development, to launch, and through their lifecycle. She has extensive global experience in early and late-stage pricing, market access strategies, value proposition development, lifecycle management, generic or biosimilar erosion counterstrategies, and patient support programs. Much of her work to date has centered around understanding the barriers to access and reimbursement challenges posed by evolving healthcare systems and evidence requirements.

Prior to Trinity Life Sciences, she was the CEO & Managing Director of CBPartners, a boutique consulting company she co-founded in 2012 and sold to Trinity Life Sciences in October of 2021.

Monica also serves on the board of Angeli Parvi, a non-profit focused on providing early-stage seed investments and mentorship to Dartmouth entrepreneurs with the goal of giving back to the Dartmouth community and growing our entrepreneurial footprint.